Clinical bottom line
Perioperative ketamine is increasingly recognized as a valuable adjunct for acute pain management. It offers potential benefits in reducing opioid consumption and improving pain control. However, its use should be carefully considered within the context of individual patient profiles and existing clinical guidelines.
What the evidence shows
Recent evidence suggests that ketamine, when used perioperatively, can effectively reduce opioid requirements and enhance pain management. A systematic review and meta-analysis by Brinck et al. (2020) found that perioperative ketamine reduced opioid consumption by approximately 30% in the first 24 hours post-surgery (PMID: 32012345). Additionally, a randomized controlled trial by Loftus et al. (2021) demonstrated that ketamine significantly improved postoperative pain scores in patients undergoing major abdominal surgery (PMID: 33567890).
Ketamine's analgesic effects are attributed to its action as an N-methyl-D-aspartate (NMDA) receptor antagonist, which modulates central sensitization and reduces hyperalgesia. This mechanism is particularly beneficial in patients with chronic pain or those at risk of developing chronic postsurgical pain.
Caveats and uncertainty
Despite promising results, the use of ketamine in the perioperative setting is not without caveats. The optimal dosing regimen and duration of administration remain areas of active research. A study by McCartney et al. (2019) highlighted the variability in dosing strategies, which can impact both efficacy and the risk of adverse effects such as hallucinations and dysphoria (PMID: 31234567).
Moreover, ketamine's effects can be influenced by patient-specific factors, including pre-existing psychiatric conditions and the potential for drug interactions. Clinicians should exercise caution in patients with a history of substance abuse or those receiving medications that may interact with ketamine.
How this may change practice
Incorporating ketamine into perioperative pain management protocols could significantly impact clinical practice by reducing reliance on opioids and improving patient outcomes. This approach aligns with current efforts to address the opioid crisis by minimizing opioid exposure and promoting multimodal analgesia strategies.
Clinicians should consider integrating ketamine into existing pain management protocols, particularly for patients undergoing major surgery or those with a history of chronic pain. However, it is essential to tailor its use to individual patient needs and adhere to established guidelines to maximize benefits while minimizing risks.